Scanwell Health Nabs $1.6M NIH Grant for its Rapid, At-Home Test for Chronic Kidney Disease

What You Must Know:

— LA-based health tech start-up Scanwell Health revealed today that it has received a $1.6 M NIH grant to accelerate the advancement of its rapid at-home test for Chronic Kidney Disease (CKD).

— CKD can be a quiet killer– the majority of people who have it
are uninformed until its far too late to deal with efficiently. If diagnosed early,
disease development can be slowed.

Scanwell Health,
a Los Angeles-based digital health business
that makes healthcare quick and easy by offering at-home lab tests, has been
awarded a $1.6 M National Institutes of Health
( NIH) Small Business Innovation Research (SBIR) grant.

— An early version of Scanwells quick at-home test is being utilized by scientists at several leading medical facilities including Johns Hopkins, the Cleveland Clinic, and the University of Pennsylvania.

NIH Grant Details

The grant will supply funds for the continued development
of Scanwells smartphone-enabled, at-home test for chronic kidney disease
( CKD). Scanwells test will make screening for and monitoring early CKD fast
and easy. The companys technology will permit clients to check themselves from
home utilizing just a urine test kit and their smart devices, leading to earlier
diagnosis and sped up care.

Why it Matters

Currently there is no cure for chronic kidney illness. In
its last phases, hemodialysis or a kidney transplant end up being required to live.
Death rates for hemodialysis patients are shockingly high—- only 42% of
patients stay alive after five years of treatment. When diagnosed
early enough, the progression of CKD to end-stage renal failure can be slowed
with medications and lifestyle interventions.

It is estimated that more than 30 million individuals in the United States
have some kind of kidney illness. Due to the asymptomatic nature of early CKD,
numerous who have it are uninformed: according to the National Kidney Foundation,
around 90% of those with CKD do not know they have it.

Scanwells at-home approach to laboratory testing is specifically
timely as the ongoing COVID-19 pandemic has actually resulted in a major shift to
telehealth. According to McKinsey, healthcare suppliers are seeing 50 to 175
times the number of clients via telehealth than prior to the pandemic.

” We want to live in a world where kidney illness never comes out of left field, however far frequently, it does,” stated Stephen Chen, Founder and CEO of Scanwell. “We established this innovation to provide an early warning, which will significantly improve the quality of life for countless individuals.”

Scanwells At-Home Test Kit Availability

Though Scanwells test is not yet commercially available,
early version is currently being utilized by researchers at Kaiser Permanente,
Johns Hopkins, Cleveland Clinic, the University of Pennsylvania and others as
part of the NIH-funded Chronic Renal Insufficiency Cohort (CRIC) Study. The brand-new
SBIR grant will allow Scanwell to continue advancement and recognition
as conduct clinical research studies prior to sending the test to the Federal Drug
Administration for review..